Data as of Apr 17
| -0.29 / -3.02%|
The 1 analysts offering 12-month price forecasts for OHR Pharmaceutical Inc have a median target of 21.00, with a high estimate of 21.00 and a low estimate of 21.00. The median estimate represents a +125.32% increase from the last price of 9.32.
The current consensus among 1 polled investment analysts is to Buy stock in OHR Pharmaceutical Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.